ivWatch, LLC

Andrew Barton of the United Kingdom’s Frimley Health NHS Foundation Trust Hospital published a clinical study on ivWatch patient monitoring for IV extravasations in the peer reviewed British Journal of Nursing (BJN) of Nursing this month. Read the full study and learn how to improve IV safety and why staff members said ivWatch technology was “like having a second pair of eyes to monitor the infusion site.” https://lnkd.in/eV4ue3A2

This baby couldn’t tell your staff something was wrong. So many patients are not able to communicate when something is going bad with their IV. This patient couldn’t express their IV was burning, that it hurt for hours or maybe even days. ivWatch can communicate to your staff even when patients can’t and earlier than physical signs are present. #ivtherapy #ivextravasation #ivpatient 

Clinical research and development stand at the epicenter of everything we do at ivWatch. We are paving the path with technologies that provide an undeniable advantage to clinicians and their patients. Our innovations are often referred to as “an extra set of eyes” or “guardian angel.” This is why we exist: TO MAKE IV THERAPY SAFER. Jaclyn Lautz, Ph.D.

Warning, when performing an IV assessment, Don't Trust the Flush as your gold standard. There are several ways in which an IV can infiltrate potentially causing severe patient harm. Many extravasation causes will still give you a good blood return or flush even though the IV is infiltrating.    Learn More: https://www.ivwatch.com/

Just in on the Patient Safety & Quality Healthcare podcast with host Jay Kumar: IV therapy expert and nurse consultant Andrew Barton discusses his holistic view on improving IV access services with technology, reducing his extravasation rates to zero. “It doesn’t just give the staff reassurance and me reassurance, as the lead for this service, but the patients as well. And that’s the most important thing, so the patients feel comfortable.” Listen to the podcast: https://lnkd.in/eSpQjfqp

While infiltration injuries threaten all patients, pediatric populations—neonates, infants, and children—are particularly vulnerable due to their fragile blood vessels, immature skin, limited subdermal fat, and constant movement.   Don't wait for these types of injuries to appear. Let's take proactive steps to safeguard these patients with early extravasation dectection technology.   Source: Peripheral Infiltration and Extravasation Injury Methodology: A Retrospective Study - PMC (nih.gov) https://lnkd.in/ebRZdy8m

ivWatch is proud to partner with clinicians to provide a reassurance of continued monitoring for patient IVs. Helen Stephens Learn more: https://lnkd.in/eahMrbcp

According to the 2024 INS guidelines, infusion pump alarms cannot be trusted to detect infiltrations and extravasations. ivWatch proudly stands as the only device to detect IV extravasations, backed by over two decades of R&D, nearly 70 global patents, and more than 30 clinical studies that clinicians confidently rely on every day around the world. Don’t continue to rely on the occlusion alarms, rely on proven technology.

Yes, this is hard to look at and imagine.   Extravasation injuries can get worse before they get better. Some linger for years, needing surgeries, skin grafts, and physical therapy to regain function in the extremity.   Let's partner together to protect your patients from this life changing harm. #ivextravasation #ivtherapy 

Our mission is simple: 𝐌𝐀𝐊𝐄 𝐈𝐕 𝐓𝐇𝐄𝐑𝐀𝐏𝐘 𝐒𝐀𝐅𝐄𝐑. We hit the road every week to discuss our holistic clinical approach to reduce serious harm from IV extravasations. Take a look back with us on our visits with az groeninge, Cincinnati Children's, St. Jude Children's Research Hospital's and University of Mississippi Medical Center (Children's of Mississippi) as well as the National Infusion Center Association (NICA) annual conference with numerous infusion centers around the states. Join us on this special patient safety journey.